Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Rocky Brands | RCKY | Nov 25, 2024 | 22.69 | +3.99 |
Rocky Mountain Chocolate Factory | RMCF | Nov 25, 2024 | 2.70 | +1.89 |
Rogers | ROG | Nov 25, 2024 | 106.86 | +0.87 |
Rogers Communications | RCI | Nov 25, 2024 | 35.88 | +1.41 |
Roivant Sciences | ROIV | Nov 25, 2024 | 12.46 | -0.56 |
Roku A | ROKU | Nov 25, 2024 | 68.22 | -1.42 |
Rollins | ROL | Nov 25, 2024 | 51.23 | +1.19 |
Roma Green Finance | ROMA | Nov 25, 2024 | 0.69 | +0.88 |
Root | ROOT | Nov 25, 2024 | 108.44 | -0.72 |
Roper Technologies | ROP | Nov 25, 2024 | 557.94 | -0.39 |
Ross Stores | ROST | Nov 25, 2024 | 153.29 | +4.93 |
Roth CH Acquisition V | ROCL | Nov 25, 2024 | 11.38 | -2.19 |
Roth CH Acquisition V Unit | ROCLU | Nov 25, 2024 | 11.25 | 0.00 |
Royal Bank Of Canada | RY | Nov 25, 2024 | 124.32 | -0.61 |
Royal Caribbean Cruises | RCL | Nov 25, 2024 | 240.39 | -0.46 |
Royal Gold | RGLD | Nov 25, 2024 | 144.88 | -2.76 |
Royalty Management Holding A | RMCO | Nov 25, 2024 | 1.03 | +0.98 |
Royalty Pharma Plc | RPRX | Nov 25, 2024 | 26.47 | +0.15 |
Royce Global Value Trust | RGT | Nov 25, 2024 | 11.80 | +0.68 |
Royce Micro-Cap Trust | RMT | Nov 25, 2024 | 10.33 | +1.47 |
Royce Small-Cap Trust | RVT | Nov 25, 2024 | 16.70 | +1.34 |
RPC | RES | Nov 25, 2024 | 6.36 | -1.09 |
RPM International | RPM | Nov 25, 2024 | 140.26 | +1.73 |
RTX | RTX | Nov 25, 2024 | 118.65 | -1.76 |
Rubrik | RBRK | Nov 25, 2024 | 50.39 | -1.29 |
Rumble | RUM | Nov 25, 2024 | 7.31 | +12.63 |
RumbleOn B | RMBL | Nov 25, 2024 | 5.68 | -10.27 |
Runway Growth Finance | RWAY | Nov 25, 2024 | 10.31 | -1.06 |
Rush Enterprises A | RUSHA | Nov 25, 2024 | 62.87 | +4.78 |
Rush Enterprises B | RUSHB | Nov 25, 2024 | 57.39 | +3.24 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.